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Spinal  Myoclonus  Developed  during  Cervical  Epidural  Drug 
Infusion  in  Postherpetic  Neuralgia  Patient
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Postherpetic neuralgia is the most frequent complication of herpes zoster. Treatment of this neuropathic 
pain syndrome is difficult and often disappointing. Although postherpetic neuralgia is generally a self-limited 
condition, it can last indefinitely. Continuous epidural blockade for patients with acute zoster can shorten 
the duration of treatment. However, continuous epidural block has some complications such as infection, dural 
puncture, and total spinal and nerve damages. We report a case of myoclonus during continuous epidural 
block with ropivacaine, morphine, and ketamine in an acute zoster patient. (Korean  J  Pain  2011;  24: 
169-171)
Key  Words: 
analgesia, complication, epidural, myoclonus.
Received April 14, 2011. Revised June 1, 2011. Accepted June 1, 2011.
Correspondence to: Jin Seok Yeo, MD
Department of Anesthesiology and Pain Medicine, Kyungpook National University Hospital, 50, Samdeok 2-ga, Jung-gu, Daegu 700-721, 
Korea
Tel:  ＋82-53-420-5863, Fax: ＋82-53-426-2760, E-mail: jsyeo@hmail.knu.ac.kr
 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// 
creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Copyright  ⓒ The Korean Pain Society, 2011
　　Postherpetic neuralgia is the most frequent complication 
of herpes zoster. Treatment of this neuropathic pain syn-
drome is difficult and often disappointing. Continuous epi-
dural blockade for patients with acute zoster can shorten 
the  duration  of  the  treatment  [1].  Continuous  epidural 
blockade has some complications such as infection, vas-
cular injection, dural puncture, total spinal anesthesia, and 
nerve damage. Spinal myoclonus after neuraxial blockade 
is very rare complication. We report a case of bilateral my-
oclonus during continuous cervical epidural block with ro-
pivacaine, morphine, and ketamine and reviewthe related 
literature. 
CASE  REPORT
　　A 61-year-old female came to our pain clinic and pre-
sented with erythematous vesicles and pain on the right 
side of her arm for 2 weeks. She had no significant past 
or family medical history. Initial physical examination of 
the patient showed grouped vesicles and crusts on an ery-
thematous  skin  lesion,  scattered  along  the  right  C5 
dermatome. The intensity of pain using the visual analogue 
scale (V AS) from 0 to 10 (0 = no pain, 10 = worst pain 
imaginable) was 8. She complained of burning and lanci-
nating pain, hyperesthesia, and sleep disturbance due to 
night pain on the affected dermatome. 170 Korean J Pain Vol. 24, No. 3, 2011
　　She  had  been  treated  with  famciclovir  (FAMVIR
Ⓡ, 
Novartis,  USA)  250  mg  3  times  a  day  and  pregabalin 
(Lyrica
Ⓡ, Pfizer Korea, Korea) 150 mg twice a day and a 
tramadol/acetaminophen  tablet  (Ultracet
Ⓡ,Yansen  Korea, 
Korea) 3 times a day orally f or 7 days. Com plete blood 
count, urine analysis, blood chemistry, electrocardiogram, 
and chest and spine radiographs were all within normal 
limits. In medicalhistory, she was free of neurological dis-
orders  such  as  cerebral  infarction,  epilepsy,  or  Parkin-
son’s disease. 
　　After discussing with the patient, continuous epidural 
analgesia was selected for treatment of the herpes-zos-
ter-induced pain. In theoutpatient department of our pain 
clinic, an 18-G epidural catheter was inserted 3 cm cepha-
lad through a 17-GTuohy needle to the C6-7 interspace. 
T h e  e p i d u r a l  s p a c e  w a s  d e t e c t e d  b y  t h e  h a n g i n g  d r o p  
technique. Catheterization of the epidural space was done, 
and no blood or cerebrospinal fluid was aspirated through 
the catheter. The patient did not complain of anypares-
thesia during the procedure. An epidural injection of 5 ml 
of 0.2% plain ropivacaine produced bilateral sensory block 
o f  t h e  C 5 - 7  d e r m a t o m e s  d e t e r m i n e d  b y  t h e  p i n p r i c k  
m e t h o d .  C o n t i n u o u s  e p i d u r a l  i n f u s i o n  w a s  s t a r t e d  w i t h  
0.2% r opi v a caine 4 m l/h and m orp hine su lf ate 0.2 mg/ 
hwith a portable disposable pump. 
　　After 7 days, she visited our outpatient pain clinic and 
her VAS score haddecreased to 5, but she still complained 
of burning sensations and lancinating pain. Therefore, we 
administered 0.2% ropivacaine 4 ml/h, morphine sulfate 
0.4 mg/h, and ketamine 1 mg/hepidurally. 
　　On the thirdday after infusion of this analgesic regi-
men, she showed bilateral involuntary movement of both 
hands. Brief, involuntary twitching of the muscle inboth 
hands persisted for about 2-3 minutes intermittently, and 
it occurred several times an hour. An MRI on the headand 
cervical spine was doneand aneurologist assessed the pa-
tient’s neurological deficits. However, there were no neu-
rological deficits,no abnormal findingson the MRI, and no 
electrolyte imbalances in the blood sample. Therefore, we 
diagnosed spinal myoclonus. Therefore, we stopped epi-
dural infusion and removed the epidural catheter. Thirty- 
six hours after stopping the infusion, her involuntary move-
m e n t  c e a se d .  W e d ec i d ed  t o m a i n t a in h e r p r e vi o us  o r a l 
medication to control for pain and discharged her without 
any complications. At that time, her V AS score was 5. 
DISCUSSION
　　Myoclonus is comprised of sudden, involuntary con-
tractions of a group of muscles, a single muscle, or part 
of a m uscl e. Spin a l, f oca l, or segm en ta l m y ocl on us has 
specific features that distinguish it from other forms of 
more generalized myoclonus. It is often restricted to one 
somatic region due to the pathology at the involved level 
of the spinal cord. The appearance of myoclonus may take 
several months oryears. The possible causes are tumor, 
i n f e c t i o n ,  t r a u m a ,  a n d  d e g e n e r a t i v e  p r o c e s s e s  [ 2 ] .  T h e  
pathophysiology  of  spinal  myoclonus  includes  abnormal 
loss of inhibition from suprasegmental descending path-
ways, loss of inhibition from local dorsal horn interneurons, 
hyperactivity  of  contiguous  anterior  horn  neurons,  and 
aberrant local axon re-excitations [3]. 
　　Neuraxial high dose opioid therapy may cause spinal 
myoclonus [4,5]. Kloke et al. [4] reported 10 cases of my-
oclonus among spinal opioid therapy patients. In addition, 
spinal cord or nerve lesions are risk factorsof myoclonus. 
Medullar spinalis lesions are associated with increased risk 
of myoclonus because of combination of spinal-cord/nerve 
dysfunction and high intrathecal or systemic opioid an-
algesia requirement [4]. In our case, the patient did not 
receive a high dose of neuraxial opioid. Additionally, she 
did not have spinal cord lesions. Therefore, this case of 
spinal myoclonus is unlikely opioid induced. 
　　Local anesthetic neurotoxicity may cause spinal my-
oclonus [6]. It was postulated that the inhibitory effects of 
the local anesthetic might have led to heightened irritability 
of  the  α- m o t o r  n e u r o n s ,  l e a d i n g  t o  m y o c l o n u s  [ 7 ] .  
However, ropivacaine used in this caseis known to be the 
least neurotoxic local anesthetics [8]. 
　　Zoster myelitis can cause spinal myoclonus [9], butit 
is not a cause of myoclonus in this case sincemyoclonus 
a p p e a r e d  a n d  d i s a p p e a r e d  a s t h e  k e t a m i n e  i n f u s i o n w a s  
started and stopped, respectively, and there were no mye-
litis lesions in the MRI. 
　　Indwelling spinal or epidural catheters may cause my-
oclonus by irritating the spinal cord or nerve roots [10]. 
This can be treated immediatelyby withdrawing the of-
fending catheter. In this case, myoclonus continued for 36 
hours  after  catheter  removal.  Therefore,  we  excluded 
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　　Ketamine may induce seizure activity [11,12]. Ketamine 
may cause seizure activity either in the form of cortical 
electroencephalograph (EEG) or clinical seizure activity in 
epileptics in whom the drug activates subcortical activity 
[11,12].  Additionally,  nutritional  andenvironmental  factors 
(smoking, alcohol, diet) and drug interactions may influ-
ence the metabolic and pharmacokinetic patterns of ket-
amine contributing to proconvulsant activity. Potter et al. 
suggested that myoclonus, as a side effect of treatment 
with morphine, is more likely to occur in patients taking 
antidepressants, antipsychotic drugs, antiemetics, or non- 
steroidal inflammatory drugs for additional analgesia [13]. 
In this case, we added ketamine for additional analgesia 
just 2 days before myoclonus developed and myoclonus re-
s o l v e d  3 6  h o u r s  a f t e r  c a t h e t e r  r e m o v a l .  T h e r e f o r e ,  w e  
postulate that the k etamine ma y be r esponsible f or the 
spinal myoclonus. 
　　The  treatment  of  spinal  myoclonus  includesthe  de-
tection  and  abolition  of  the  etiology  and  symptomatic 
treatment  with  benzodiazepines  or  anticonvulsants  [3]. 
Discontinuation of drugs suspected of causing myoclonus 
and  treatment  of  metabolic  derangements  may  resolve 
some cases of myoclonus. When pharmacological treat-
m e n t  i s  i n d i c a t e d ,  a n t i c o n v u l s a n t s  a r e  t h e  m a i n  l i n e  o f 
treatment. Treatment of myoclonus focuses on medications 
that may help reduce symptoms. The various drugs used 
include anticonvulsants such as sodium valproate, clona-
zepam, and benzodiazepines, which include diazepam and 
midazolam [14]. 
　　In conclusion, spinal myoclonus following epidural an-
algesia is rare, but the clinician should watch out for this 
complication, especially in patients using morphine and an 
adjuvant drug. 
REFERENCES
1. Si m WS,  Cho i  J H,  Ha n KR,  Ki m Y C.  T r ea t me nt  o f  he r pe s 
zoster and postherpetic neuralgia. Korean J Pain 2008; 21: 
93-105.
2. Hoehn  MM,  Cherington  M.  Spinal  myoclonus.  Neurology 
1977; 27: 942-6.
3. Caviness JN, Brown P. Myoclonus: current concepts and 
recent advances. Lancet Neurol 2004; 3: 598-607.
4. Kloke M, Bingel U, Seeber S. Complications of spinal opioid 
therapy: myoclonus, spastic muscle tone and spinal jerking. 
Support Care Cancer 1994; 2: 249-52.
5 . C a r t w r i g h t  P D ,  H e s s e  C ,  J a c k s o n  A O .  M y o c l o n i c  s p a s m s  
f ollowing intrathecal diamorphine. J Pain Symptom Manage 
1993; 8: 492-5.
6. Fox EJ, Villanueva R, Schutta HS. Myoclonus following spinal 
anesthesia. Neurology 1979; 29: 379-80.
7. Menezes FV, Venkat N. Spinal myoclonus following combined 
spinal-epidural anaesthesia for Caesarean section. Anaes-
thesia 2006; 61: 597-600.
8. Y amashita A, Matsumoto M, Matsumoto S, Itoh M, Kawai K, 
Sakabe T. A comparison of the neurotoxic effects on the 
spinal  cord  of  tetracaine,  lidocaine,  bupivacaine,  and 
ropivacaine administered intrathecally in rabbits. Anesth Analg 
2003; 97: 512-9.
9 . J a n k o v i c  J ,  P a r d o  R .  S e g m e n t a l  m y o c l o n u s .  C l i n i c a l  a n d  
pharmacologic study. Arch Neurol 1986; 43: 1025-31.
1 0 .F o r d  B ,  P u l l m a n  S L ,  K h a n d j i  A ,  G o o d m a n  R .  S p i n a l  
myoclonus induced by an intrathecal catheter. Mov Disord 
1997; 12: 1042-5.
1 1 . M o r i  K ,  K a w a m a t a  M ,  M i t a n i  H ,  Y a m a z a k i  Y ,  F u j i t a  M .  A  
neurophysiologic  study  of  ketamine  anesthesia  in  the  cat. 
Anesthesiology 1971; 35: 373-83.
1 2 . H i r s h m a n  C A ,  K r i e g e r  W ,  L i t t l e j o h n  G ,  L e e  R ,  J u l i e n  R .  
Ketamine-aminophylline-induced  decrease  in  seizure 
threshold. Anesthesiology 1982; 56: 464-7.
1 3 . P o t t e r  J M ,  R e i d  D B ,  S h a w  R J ,  H a c k e t t  P ,  H i c k m a n  P E .  
Myoclonus  associated  with  treatment  with  high  doses  of 
morphine: the role of supplemental drugs. BMJ 1989; 299: 
150-3.
14. Andrade DM, Hamani C, Minassian BA. Treatment options for 
epileptic myoclonus and epilepsy syndromes associated with 
myoclonus. Expert Opin Pharmacother 2009; 10: 1549-60.